Page last updated: 2024-10-26

3,4-dihydroxybenzohydroxamic acid and Vomiting

3,4-dihydroxybenzohydroxamic acid has been researched along with Vomiting in 1 studies

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Research Excerpts

ExcerptRelevanceReference
" Pharmacokinetic studies showed that a peak level of didox was achieved within 5 minutes of injection."1.27A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor. ( Blackie, R; Cantwell, BM; Carmichael, J; Elford, HL; Harris, AL; Kaye, SB; Kerr, DJ; Veale, D, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Veale, D1
Carmichael, J1
Cantwell, BM1
Elford, HL1
Blackie, R1
Kerr, DJ1
Kaye, SB1
Harris, AL1

Other Studies

1 other study available for 3,4-dihydroxybenzohydroxamic acid and Vomiting

ArticleYear
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor.
    British journal of cancer, 1988, Volume: 58, Issue:1

    Topics: Adult; Aged; Drug Evaluation; Female; Humans; Hydroxamic Acids; Liver Function Tests; Male; Middle A

1988